Upregulation of SATB1 promotes tumor growth and metastasis in liver cancer.
about
Wnt/β-catenin signaling regulated SATB1 promotes colorectal cancer tumorigenesis and progressionAnalysis of cellular and molecular antitumor effects upon inhibition of SATB1 in glioblastoma cells.SATB1 plays an oncogenic role in esophageal cancer by up-regulation of FN1 and PDGFRB.Overexpression of SATB1 is associated with biologic behavior in human renal cell carcinoma.Genome organizing function of SATB1 in tumor progression.Aberrant SATB1 expression is associated with Epstein-Barr virus infection, metastasis and survival in human nasopharyngeal cells and endemic nasopharyngeal carcinomaCrystal structure of the ubiquitin-like domain-CUT repeat-like tandem of special AT-rich sequence binding protein 1 (SATB1) reveals a coordinating DNA-binding mechanism.Silencing SATB1 inhibits the malignant phenotype and increases sensitivity of human osteosarcoma U2OS cells to arsenic trioxide.Prognostic and treatment predictive significance of SATB1 and SATB2 expression in pancreatic and periampullary adenocarcinoma.Identification of special AT-rich sequence binding protein 1 as a novel tumor antigen recognized by CD8+ T cells: implication for cancer immunotherapyPlakoglobin represses SATB1 expression and decreases in vitro proliferation, migration and invasion.SATB1 overexpression regulates the development and progression in bladder cancer through EMT.SATB1 and 2 in colorectal cancer.The histidine-rich calcium binding protein (HRC) promotes tumor metastasis in hepatocellular carcinoma and is upregulated by SATB1.Divergent expression patterns of SATB1 mRNA and SATB1 protein in colorectal cancer and normal tissues.Molecular correlates and prognostic significance of SATB1 expression in colorectal cancer.SATB1 and SATB2 play opposing roles in c-Myc expression and progression of colorectal cancer.Special AT-rich sequence-binding protein 1 promotes cell growth and metastasis in colorectal cancer.Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway.Special AT-rich sequence binding protein 1 expression correlates with response to preoperative radiotherapy and clinical outcome in rectal cancer.SATB1 expression is correlated with β-catenin associated epithelial-mesenchymal transition in colorectal cancerUpregulation of special AT-rich-binding protein 1 by Epstein-Barr virus latent membrane protein 1 in human nasopharyngeal cells and nasopharyngeal cancer.Over-expression of the special AT rich sequence binding protein 1 (SATB1) promotes the progression of nasopharyngeal carcinoma: association with EBV LMP-1 expression.Hepatic SATB1 induces paracrine activation of hepatic stellate cells and is upregulated by HBx.Special AT-rich DNA-binding protein-1 expression is associated with liver cancer metastasis.Hepatocellular carcinoma and other malignancies in autoimmune hepatitis.Silencing SATB1 influences cell invasion, migration, proliferation, and drug resistance in nasopharyngeal carcinomaSATB2 is localized to the centrosome and spindle maintenance and its knockdown leads to downregulation of CDK2.Downregulation of SATB1 increases the invasiveness of Jurkat cell via activation of the WNT/β-catenin signaling pathway in vitro.Oncolytic virus carrying shRNA targeting SATB1 inhibits prostate cancer growth and metastasis.Up-regulation of SPOCK1 induces epithelial-mesenchymal transition and promotes migration and invasion in esophageal squamous cell carcinoma.Suppressive effect of SATB1 on hepatic stellate cell activation and liver fibrosis in rats.miR-23a suppresses proliferation of osteosarcoma cells by targeting SATB1.Tetramerization of SATB1 is essential for regulating of gene expression.Silencing SATB1 inhibits proliferation of human osteosarcoma U2OS cells.Silencing SATB1 with siRNA inhibits the proliferation and invasion of small cell lung cancer cells.Special AT-rich sequence-binding protein 1: a novel biomarker predicting cervical squamous cell carcinoma prognosis and lymph node metastasis.Pilot study special AT-rich sequence-binding protein 1 investigating as a potential biomarker for esophageal squamous cell carcinoma.SATB1 promotes epithelial-mesenchymal transition and metastasis in prostate cancer.Expression of the global regulator SATB1 is an independent factor of poor prognosis in high grade epithelial ovarian cancer.
P2860
Q28314996-741EA56B-6274-430B-A9D7-45DF92E13A7CQ30366162-A29393B4-12E7-4CE9-86F1-9EEC07BFFB8AQ33566670-2953AD1F-2AE6-4768-8230-6FF81A3BFFCCQ33623663-D68BA0E0-37A2-45A9-BB5E-271088DCDFDFQ33720872-4496ECC8-D3B2-4377-9520-5D85A410E0E9Q33803028-8B860924-BD85-4F56-A244-455EDB87A9ECQ34283347-36EDDF3E-63D3-4A45-83FE-5BEE8F0A3991Q34334216-2CB16235-359D-4739-8B1D-753A0C2D68D3Q34515112-713BD842-4D52-4A8C-9AD1-75B6611E2EA9Q34599387-71F0C1C2-FC53-46A0-A9EA-7DB69CF28955Q35048067-FA762145-0079-4B26-9645-F38091395A4AQ35112651-EBDB81A6-47DA-42F5-BB87-5FD006127317Q35452140-9EE1BE5A-0026-4F89-AE68-400E7656FC14Q35740079-00A7C75E-2C4D-424C-B0EF-404EF0F02A53Q35929411-63D18B70-37F5-4722-8EA9-407381816DE5Q36468662-B46821CB-ED99-4272-8BC6-B658B5D8CE2CQ36782652-9272C7D3-6572-4107-9D46-19801CD9C6CCQ36783174-3A743753-4948-42B6-B115-0EA7361F3315Q36826846-A3794D3D-B0D3-4EF6-A0A7-A46450D64D51Q36843783-4F0DBB3B-536D-434F-BDE9-81518722962EQ36844316-B59EBEC7-CA05-4D8E-AF0B-5B9CB784697AQ37006707-6CE72D93-0CEE-4C71-A9FF-BB2410955ED9Q37363343-BF61FC08-1047-4E55-8B24-A7C17D2DEC33Q37435158-15FA7474-8B49-48FD-90FD-96CB0C2E89ABQ37581990-215C4BB9-0A94-4473-9607-17AB0813DE06Q38073121-5D61EF4B-2D16-45CB-A72A-09FFF8A93511Q38574951-BD4BAFDC-C2A0-4369-A085-84B82A450B22Q38808189-D52A4EC1-07D8-424D-878F-E03F5A9EB700Q38810947-211DDCE9-489E-4E80-95A3-B76555D6610CQ38862880-C3317A43-9121-4A43-AF2C-EF87105256BAQ38863790-F3D8BFE7-1AE5-449F-8453-3D900F199DF2Q38884278-DEDECB74-DA07-4166-B04F-786745359476Q38916701-08735206-6155-404D-87CF-DCAF51CC8031Q38958512-31A60475-B50A-479D-97A7-08945AAC4744Q39177846-58CED156-A0BD-4DD2-AE47-5E41B10B76DEQ39199933-8DD26F87-D7E6-48C1-9E85-C346BFE3C154Q41635840-7F235407-6D05-4258-894F-823594453907Q41755567-C83DFE25-5F58-424A-8626-36C6845437FAQ41833714-30AF6BFD-E819-4CB0-9D14-7487E8AACB8BQ42424860-E1C9ED28-0BF4-4D7A-BC8E-483A43CCFB5E
P2860
Upregulation of SATB1 promotes tumor growth and metastasis in liver cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Upregulation of SATB1 promotes tumor growth and metastasis in liver cancer.
@en
Upregulation of SATB1 promotes tumor growth and metastasis in liver cancer.
@nl
type
label
Upregulation of SATB1 promotes tumor growth and metastasis in liver cancer.
@en
Upregulation of SATB1 promotes tumor growth and metastasis in liver cancer.
@nl
prefLabel
Upregulation of SATB1 promotes tumor growth and metastasis in liver cancer.
@en
Upregulation of SATB1 promotes tumor growth and metastasis in liver cancer.
@nl
P2093
P2860
P1433
P1476
Upregulation of SATB1 promotes tumor growth and metastasis in liver cancer.
@en
P2093
Zhijun Wang
P2860
P304
P356
10.1111/J.1478-3231.2012.02815.X
P577
2012-05-14T00:00:00Z